Keywords
MedicineClinical trialIntensive care medicineMedical physicsMEDLINEEndpoint DeterminationInternal medicine
Related Publications
Imaging for Assessment of Radiation-Induced Normal Tissue Effects
Imaging can provide quantitative assessment of radiation-induced normal tissue effects. Identifying an early sign of normal tissue damage with imaging would have the potential t...
Surrogate Markers in AIDS: Where Are We? Where Are We Going?
Editorials1 April 1992Surrogate Markers in AIDS: Where Are We? Where Are We Going?Stephen W. Lagakos, PhD, Daniel F. Hoth, MDStephen W. Lagakos, PhD, Daniel F. Hoth, MDAuthor, A...
Selection of endpoints for clinical trials of acute renal failure in critically ill patients
The selection of appropriate outcome measures is essential to the design of clinical trials of the prevention or treatment of acute renal failure in critically ill patients. In ...
Clinical End Points in Coronary Stent Trials
Background— Although most clinical trials of coronary stents have measured nominally identical safety and effectiveness end points, differences in definitions and timing of asse...
Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
Cumulative meta-analysis of therapeutic trials facilitates the determination of clinical efficacy and harm and may be helpful in tracking trials, planning future trials, and mak...
Publication Info
- Year
- 1983
- Type
- article
- Volume
- 9
- Issue
- 5
- Pages
- 758-62
- Citations
- 138
- Access
- Closed
External Links
Citation Metrics
138
OpenAlex
Cite This
Peter Tugwell,
Claire Bombardier
(1983).
A methodologic framework for developing and selecting endpoints in clinical trials..
PubMed
, 9
(5)
, 758-62.